United States. Congress. House. Committee on Oversight and Reform

Sort by

1) Facial recognition technology: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress

Author

Pub. Date

2019-

Physical Description

3 volumes ; 24 cm

Language

English

2) Trump administration's response to the drug crisis: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, March 7, 2019

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2019-

Physical Description

volumes ; 24 cm

Language

English

3) Identifying, preventing, and treating childhood trauma: a pervasive public health issue that needs greater federal attention : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth...

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2019.

Physical Description

iii, 68 pages ; 24 cm + errata (2 unnumbered pages)

Language

English

4) Violations of the Hatch Act under the Trump Administration: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2019-

Physical Description

volumes ; 24 cm

Language

English

5) Unsustainable drug prices: hearing before the Committee on Oversight and Reform, House of Representatives

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2020-2021.

Physical Description

3 volumes ; 24 cm

Language

English

6) Authorization and oversight plans for all House committees, by the Committee on Oversight and Reform, House of Representatives (required by House rule X, clause 2)

Author

United States. Congress. House. Committee on Oversight and Reform

Series

House report

Pub. Date

2019-

Physical Description

volumes.

Language

English

7) The role of Purdue Pharma and the Sackler family in the opioid epidemic: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2021.

Physical Description

iii, 62 pages ; 24 cm + 2 errata (2 pages)

Language

English

8) Acting Secretary of Homeland Security Kevin K. McAleenan: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, July 18, 2019

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2019.

Physical Description

iii, 69 pages ; 24 cm

Language

English

9) The administration's religious liberty assault on LGBTQ rights: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, February 27, 2020

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2020.

Physical Description

iv, 58 pages ; 24 cm

Language

English

10) Executive Branch Comprehensive Ethics Enforcement Act of 2019: report together with minority views (to accompany H.R. 745) (including cost estimate of the Congressional Budget Office)

Author

United States. Congress. House. Committee on Oversight and Reform

Series

Rept. / 116th Congress 2d session House of Representatives volume 116-403

Pub. Date

[2020]-

Physical Description

volumes ; 24 cm

Language

English

11) No worker left behind: supporting essential workers : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, June 10, 2020

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2020.

Physical Description

iii, 54 pages ; 24 cm

Language

English

12) The financial condition of the Postal Service: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, April 30, 2019

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2019.

Physical Description

iii, 53 pages ; 24 cm

Language

English

13) Resolution recommending that the House of Representatives find William P. Barr, Attorney General of the United States, and Wilbur L. Ross, Jr., Secretary of Commerce, in...: report of the Committee on Oversight and Reform, House of Representatives, together with minority and supplemental views

Author

United States. Congress. House. Committee on Oversight and Reform

Series

Report / 116th Congress 1st session House of Representatives volume 116-125

Pub. Date

2019.

Physical Description

iii, 1,087 pages : illustrations ; 24 cm

Language

English

14) The Capitol Insurrection: unexplained delays and unanswered questions : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2021.

Physical Description

2 volumes ; 24 cm

Language

English

15) Federal Risk and Authorization Management Program Authorization Act of 2019: report (to accompany H.R. 3941) (including cost estimate of the Congressional Budget Office)

Author

United States. Congress. House. Committee on Oversight and Reform

Series

Report / 116th Congress 2d session House of Representatives volume 116-391

Pub. Date

[2020]

Physical Description

23 pages ; 24 cm

Language

English

16) Examining state efforts to undermine access to reproductive health care: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, November 14, 2019

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2020.

Physical Description

iii, 57 pages ; 24 cm

Language

English

17) The devastating health impacts of climate change: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, August 5, 2020

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2020.

Physical Description

iii, 58 pages ; 24 cm

Language

English

18) HIV prevention drug: billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth...

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2019.

Physical Description

iii, 63 pages ; 24 cm

Language

English

19) DoD Inspector General report on excess profits by TransDigm Group, Inc: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 15, 2019

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2019.

Physical Description

iii, 49 pages ; 24 cm

Language

English

20) The patient perspective: the devastating impacts of skyrocketing drug prices on American families : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth...

Author

United States. Congress. House. Committee on Oversight and Reform

Pub. Date

2019.

Physical Description

iii, 41 pages ; 24 cm

Language

English

Navigation

Main Navigation

Filter Results

Narrow Your Results

United States. Congress. House. Committee on Oversight and Reform

1) Facial recognition technology: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress

2) Trump administration's response to the drug crisis: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, March 7, 2019

3) Identifying, preventing, and treating childhood trauma: a pervasive public health issue that needs greater federal attention : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth...

4) Violations of the Hatch Act under the Trump Administration: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session

5) Unsustainable drug prices: hearing before the Committee on Oversight and Reform, House of Representatives

6) Authorization and oversight plans for all House committees, by the Committee on Oversight and Reform, House of Representatives (required by House rule X, clause 2)

7) The role of Purdue Pharma and the Sackler family in the opioid epidemic: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, December 17, 2020

8) Acting Secretary of Homeland Security Kevin K. McAleenan: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, July 18, 2019

9) The administration's religious liberty assault on LGBTQ rights: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, February 27, 2020

10) Executive Branch Comprehensive Ethics Enforcement Act of 2019: report together with minority views (to accompany H.R. 745) (including cost estimate of the Congressional Budget Office)

11) No worker left behind: supporting essential workers : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, June 10, 2020

12) The financial condition of the Postal Service: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, April 30, 2019

13) Resolution recommending that the House of Representatives find William P. Barr, Attorney General of the United States, and Wilbur L. Ross, Jr., Secretary of Commerce, in...: report of the Committee on Oversight and Reform, House of Representatives, together with minority and supplemental views

14) The Capitol Insurrection: unexplained delays and unanswered questions : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session

15) Federal Risk and Authorization Management Program Authorization Act of 2019: report (to accompany H.R. 3941) (including cost estimate of the Congressional Budget Office)

16) Examining state efforts to undermine access to reproductive health care: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, November 14, 2019

17) The devastating health impacts of climate change: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, August 5, 2020

18) HIV prevention drug: billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth...

19) DoD Inspector General report on excess profits by TransDigm Group, Inc: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 15, 2019

20) The patient perspective: the devastating impacts of skyrocketing drug prices on American families : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth...